We provide the latest news
from the world of economics and financeBargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to make a purchase, is that they expect to make money. Today we look at two noteworthy recent insider buys.
On Monday, Biohaven's, John W. Childs, made a $1.00M purchase of BHVN, buying 28,500 shares at a cost of $35.17 each. Biohaven is trading up about 5.5% on the day Tuesday. Before this latest buy, Childs purchased BHVN on 4 other occasions during the past twelve months, for a total cost of $20.90M at an average of $26.14 per share.
And at Treace Medical Concepts, there was insider buying on Friday, by John K. Bakewell who bought 130,000 shares at a cost of $4.57 each, for a trade totaling $594,620. This purchase marks the first one filed by Bakewell in the past year. Treace Medical Concepts is trading up about 22.7% on the day Tuesday. So far Bakewell is in the green, up about 32.9% on their purchase based on today's trading high of $6.08.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.